Is there a rationale for the continuous infusion of cefepime? A multidisciplinary approachBERNARD, E; BREILH, D; BRU, J.-P et al.Clinical microbiology and infection. 2003, Vol 9, Num 5, pp 339-348, issn 1198-743X, 10 p.Article

Continuous Epileptiform Discharges in Patients Treated With Cefepime or MeropenemNAEIJE, Gilles; LORENT, Sophie; VINCENT, Jean-Louis et al.Archives of neurology (Chicago). 2011, Vol 68, Num 10, pp 1303-1307, issn 0003-9942, 5 p.Article

Stability of cefepime hydrochloride in AutoDose infusion system bagsTRISSEL, Lawrence A; XU, Quanyun A.The Annals of pharmacotherapy. 2003, Vol 37, Num 6, pp 804-807, issn 1060-0280, 4 p.Article

SHV-type extended-spectrum beta-lactamase production is associated with reduced cefepime susceptibility in Enterobacter cloacaeSZABO, Dora; BONOMO, Robert A; SILVEIRA, Fernanda et al.Journal of clinical microbiology (Print). 2005, Vol 43, Num 10, pp 5058-5064, issn 0095-1137, 7 p.Article

Efficacy and safety of cefepimeTOWNE, Trent G; LEWIS, James S; ECHEVARRIA, Kelly et al.Lancet. Infectious diseases (print). 2009, Vol 9, Num 1, pp 4-7, issn 1473-3099, 4 p.Article

Efficacy and safety of cefepime : a systematic review and meta-analysisYAHAV, Dofna; PAUL, Mical; FRASER, Abigail et al.Lancet. Infectious diseases (print). 2007, Vol 7, Num 5, pp 338-348, issn 1473-3099, 11 p.Article

Comparison of the probability of target attainment between ceftriaxone and cefepime in the cerebrospinal fluid and serum against Streptococcus pneumoniaeLODISE, Thomas P; NAU, Roland; KINZIG, Martina et al.Diagnostic microbiology and infectious disease. 2007, Vol 58, Num 4, pp 445-452, issn 0732-8893, 8 p.Article

Comparisons of parenteral broad-spectmm cephalosporins tested against bacterial isolates from pediatric patients : report from the SENTRY Antimicrobial Surveillance Program (1998-2004)JONES, Ronald N; SADER, Helio S; FRITSCHE, Thomas R et al.Diagnostic microbiology and infectious disease. 2007, Vol 57, Num 1, pp 109-116, issn 0732-8893, 8 p.Article

Pharmacokinetics of cefepime in bile and gall bladder tissue after prophylactic administration in patients with extrahepatic biliary diseasesPETRIKKOS, George; KASTANAKIS, Miltiadis; MARKOGIANNAKIS, Antonios et al.International journal of antimicrobial agents. 2006, Vol 27, Num 4, pp 331-334, issn 0924-8579, 4 p.Article

Comparative activities of cefepime and piperacillin/tazobactam tested against a global collection of Escherichia coli and Klebsiella spp. with an ESBL phenotypeSADER, Helio S; HSIUNG, Andre; FRITSCHE, Thomas R et al.Diagnostic microbiology and infectious disease. 2007, Vol 57, Num 3, pp 341-344, issn 0732-8893, 4 p.Article

Multicentre study of the in vitro activity of cefepime, a broad-spectrum cephalosporin, compared to other broad-spectrum agentsBELL, Jan M; TURNIDGE, John D.Pathology (Sydney). 2001, Vol 33, Num 1, pp 53-60, issn 0031-3025Article

Pharmacokinetics of Fusidic Acid and Cefepime in Heart Tissues : Implications for a Role in Surgical ProphylaxisKANELLAKOPOULOU, K; TSELIKOS, D; GIANNITSIOTI, E et al.Journal of chemotherapy. 2008, Vol 20, Num 4, pp 468-471, issn 1120-009X, 4 p.Article

Population pharmacokinetics of cefepime in neonates with severe nosocomial infectionsLIMA-ROGEL, V; MEDINA-ROJAS, E. L; MILAN-SEGOVIA, R. Del Carmen et al.Journal of clinical pharmacy and therapeutics (Print). 2008, Vol 33, Num 3, pp 295-306, issn 0269-4727, 12 p.Article

Électroencéphalogramme pseudopériodique dans l'encéphalopathie due au céfépime = Pseudoperiodic EEG heralding a cefepime-induced encephalopathySAGOT, N; DE BROUCKER, T; ESQUIVEL-WALLS, E et al.Revue neurologique (Paris). 2007, Vol 163, Num 11, pp 1122-1123, issn 0035-3787, 2 p.Article

Subcutaneous administration of cefepimeWALKER, Paul; NEUHAUSER, Melinda N; TAM, Vincent H et al.Journal of pain and symptom management. 2005, Vol 30, Num 2, pp 170-174, issn 0885-3924, 5 p.Article

Potency and spectrum trends for cefepime tested against 65 746 clinical bacterial isolates collected in North American medical centers : Results from the SENTRY Antimicrobial Surveillance Program (1998-2003)SADER, Helio S; FRITSCHE, Thomas R; JONES, Ronald N et al.Diagnostic microbiology and infectious disease. 2005, Vol 52, Num 3, pp 265-273, issn 0732-8893, 9 p.Article

Reevaluation of the cefepime minimal inhibitory concentrations and disk diffusion test zone diameter relationship for a worldwide collection of Enterobacteriaceae enriched for extended-spectrum β-lactamase-producing organismsPOTTUMARTHY, Sudha; DESHPANDE, Lalitagauri M; SADER, Helio S et al.Diagnostic microbiology and infectious disease. 2005, Vol 52, Num 2, pp 95-99, issn 0732-8893, 5 p.Article

Therapeutic options among broad-spectrum β-lactams for infections caused by levofloxacin-nonsusceptible Streptococcus pneumoniaeJONES, Ronald N; FRITSCHE, Thomas R; SADER, Helio S et al.Diagnostic microbiology and infectious disease. 2005, Vol 52, Num 2, pp 129-133, issn 0732-8893, 5 p.Article

Changes in the Use of Broad-Spectrum Antibiotics after Cefepime Shortage: a Time Series AnalysisPLÜSS-SUARD, C; PANNATIER, A; RUFFIEUX, C et al.Antimicrobial agents and chemotherapy. 2012, Vol 56, Num 2, pp 989-994, issn 0066-4804, 6 p.Article

Population pharmacokinetics of cefepime in the neonateCAPPARELLI, Edmund; HOCHWALD, Christine; RASMUSSEN, Maynard et al.Antimicrobial agents and chemotherapy. 2005, Vol 49, Num 7, pp 2760-2766, issn 0066-4804, 7 p.Article

Comparison of ^99mTc-DTPA and urea for measuring cefepime concentrations in epithelial lining fluidBAYAT, S; LOUCHAHI, K; VERDIERE, B et al.The European respiratory journal. 2004, Vol 24, Num 1, pp 150-156, issn 0903-1936, 7 p.Article

Determination of cefepime and cefpirome in human serum by high-performance liquid chromatography using an ultrafiltration for antibiotics serum extractionBREILH, D; LAVALLEE, C; FRATTA, A et al.Journal of chromatography. B, Biomedical sciences and applications. 1999, Vol 734, Num 1, pp 121-127, issn 1387-2273Article

Cefepime neurotoxicity despite renal adjusted dosingVENU GOPALA REDDY GANGIREDDY; MITCHELL, Lauren C; COLEMAN, Teresa et al.Scandinavian journal of infectious diseases. 2011, Vol 43, Num 10, pp 827-829, issn 0036-5548, 3 p.Article

Meta-Analysis of a Possible Signal of Increased Mortality Associated with Cefepime UseKIM, Peter W; WU, Yu-Te; COOPER, Charles et al.Clinical infectious diseases. 2010, Vol 51, Num 4, pp 381-389, issn 1058-4838, 9 p.Article

Susceptibilities of Propionibacterium acnes ophthalmic isolates to ertapenem, meropenem, and cefepimeSHAMES, Robert; SATTI, Farhana; VELLOZZI, Ernestine M et al.Journal of clinical microbiology (Print). 2006, Vol 44, Num 11, pp 4227-4228, issn 0095-1137, 2 p.Article